SI-BONE Q3 net loss narrows 21% year on year to $3.62 million; Q3 revenue rises 15% year on year to $55.7 million

Bitget2026/11/02 21:21

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

SI-BONE’s third-quarter 2026 net loss narrowed 21% year over year to $3.62 million.
Revenue rose 15% to $55.7 million, while U.S. procedure volume increased 20% year over year.
September’s FDA clearance for iFuse Granite Onyx opens an estimated $1.5 billion annual addressable market targeting spine-fusion failures.
FY26 revenue guidance remains $231 million–$233 million, while expected operating expense growth was lowered to 10.5%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SI-BONE Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021609PRIMZONEFULLFEED9868332) on November 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

SI-BONE Q3 net loss narrows 21% year on year to $3.62 million; Q3 revenue rises 15% year on year to $55.7 million

You may also like

Crypto prices